Preliminar analysis of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC): NORA trial (GECP 15/02)

Annals of Oncology ◽

10.1093/annonc/mdx379.007 ◽

2017 ◽

Vol 28 ◽

pp. v459

Author(s):

M. Majem Tarruella ◽

L. Isla Casado ◽

M. Guirado ◽

B. Massuti Sureda ◽

A.L. Ortega Granados ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Cancer Group

Download Full-text

NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC)

Annals of Oncology ◽

10.1093/annonc/mdz259.004 ◽

2019 ◽

Vol 30 ◽

pp. v594

Author(s):

M. Guirado ◽

M. Majem ◽

B. Massuti Sureda ◽

R. de las Penas Bataller ◽

A.L. Ortega Granados ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Cancer Group

Download Full-text

NORA trial (GECP 15/02): First efficacy results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.8537 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 8537-8537 ◽

Cited By ~ 1

Author(s):

Dolores Isla ◽

Margarita Majem ◽

Maria Guirado ◽

Bartomeu Massuti ◽

Ramon De Las Penas ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Cancer Group

Download Full-text

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.237 ◽

2018 ◽

Vol 13 (10) ◽

pp. S320-S321 ◽

Cited By ~ 9

Author(s):

S. Lin ◽

X. Lin ◽

D. Clay ◽

L. Yao ◽

I. Mok ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Chemoradiation Therapy ◽

Small Cell Lung

Download Full-text

S-1 Plus Cisplatin with Concurrent Radiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Multi-Institutional Phase II Trial (West Japan Thoracic Oncology Group 3706)

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182307e5a ◽

2011 ◽

Vol 6 (12) ◽

pp. 2069-2075 ◽

Cited By ~ 29

Author(s):

Yukito Ichinose ◽

Takashi Seto ◽

Tomonari Sasaki ◽

Takeharu Yamanaka ◽

Isamu Okamoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Concurrent Radiotherapy

Download Full-text

Randomized Phase II Trial of Metformin in Combination with Chemoradiotherapy (CRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC); the OCOG-ALMERA trial (NCT02115464)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.2284 ◽

2020 ◽

Vol 108 (3) ◽

pp. S104

Author(s):

T. Tsakiridis ◽

G. Pond ◽

J. Wright ◽

P. Ellis ◽

B.S. Abdulkarim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Randomised Phase II Trial of Oral Vinorelbine (N) and Cisplatin (P) or Pemetrexed and C (PC) in First Line Advanced Non Squamous (NSCC) Non Small Cell Lung Cancer (NSCLC) Patients (PTS). Navotrial01: Final Results

Annals of Oncology ◽

10.1016/s0923-7534(20)33841-2 ◽

2012 ◽

Vol 23 ◽

pp. ix409

Author(s):

E.H. Tan ◽

L. Havel ◽

M.J. Krzakowski ◽

J. Kollmeier ◽

R. Gervais ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Oral Vinorelbine ◽

Nsclc Patients

Download Full-text

P-596 Radiotherapy (RT) with concurrent paclitaxel plus carboplatin and paclitaxel administered as induction and consolidation chemotherapy (CT) in locally advanced non small cell lung cancer (NSCLC). Phase II trial

Lung Cancer ◽

10.1016/s0169-5002(03)92563-3 ◽

2003 ◽

Vol 41 ◽

pp. S242

Author(s):

Vin˜olas Nuria ◽

Casas Francesc ◽

Reguart Noemi ◽

Martin Marta ◽

Palmero Ramon ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Consolidation Chemotherapy

Download Full-text

A phase II trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy in locally advanced non-small cell lung cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2010.03.011 ◽

2010 ◽

Vol 95 (2) ◽

pp. 258

Author(s):

Gianpiero Catalano ◽

Gaia Piperno ◽

Roberto Orecchia

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Accelerated Radiotherapy

Download Full-text

Phase II trial of combined modality therapy (cmt) with myeloid growth factors in patients with locally advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7567 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7567-7567

Author(s):

R. Lilenbaum ◽

M. Samuels ◽

M. Taffaro-Neskey ◽

M. Cusnir ◽

J. Pizzolato ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factors ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Combined Modality Therapy ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung

Download Full-text

P-225 XPD and RRM1 gene polymorphisms predict gemcitabine (gem)/cisplatin (cis)/docetaxel (doc) outcome in stage III non-small-cell lung cancer (NSCLC): a genetic analysis of the Spanish Lung Cancer Group phase II trial 9901

Lung Cancer ◽

10.1016/s0169-5002(03)92194-5 ◽

2003 ◽

Vol 41 ◽

pp. S148 ◽

Cited By ~ 1

Author(s):

Carme Sarries ◽

Pilar Garrido ◽

Laura Nun˜ez ◽

Barbara Roig ◽

Jose Luis Ramirez ◽

...

Keyword(s):

Lung Cancer ◽

Genetic Analysis ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Gene Polymorphisms ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Cancer Group

Download Full-text